Search details
1.
Rationale for a New Classification of Solutes of Interest in Chronic Kidney Disease and Hemodialysis.
Blood Purif
; 52(3): 242-254, 2023.
Article
in English
| MEDLINE | ID: mdl-36657410
2.
A tRial Evaluating Mid Cut-Off Value Membrane Clearance of Albumin and Light Chains in HemoDialysis Patients: A Safety Device Study.
Blood Purif
; 49(4): 468-478, 2020.
Article
in English
| MEDLINE | ID: mdl-31968346
3.
The ethics of treating family members.
Curr Opin Anaesthesiol
; 32(2): 169-173, 2019 Apr.
Article
in English
| MEDLINE | ID: mdl-30817390
4.
Large uremic toxins: an unsolved problem in end-stage kidney disease.
Nephrol Dial Transplant
; 33(suppl_3): iii6-iii11, 2018 10 01.
Article
in English
| MEDLINE | ID: mdl-30281131
5.
The treatment of paraprotein-related kidney disease.
Curr Opin Nephrol Hypertens
; 26(6): 477-483, 2017 11.
Article
in English
| MEDLINE | ID: mdl-28885307
6.
Patients with multiple myeloma have excellent long-term outcomes after recovery from dialysis-dependent acute kidney injury.
Eur J Haematol
; 96(6): 610-7, 2016 Jun.
Article
in English
| MEDLINE | ID: mdl-26248588
7.
Laboratory testing in monoclonal gammopathy of renal significance (MGRS).
Clin Chem Lab Med
; 54(6): 929-37, 2016 Jun 01.
Article
in English
| MEDLINE | ID: mdl-27107835
8.
Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysis.
Clin Chem Lab Med
; 54(6): 1045-52, 2016 Jun 01.
Article
in English
| MEDLINE | ID: mdl-26684350
9.
Diagnosis of monoclonal gammopathy of renal significance.
Kidney Int
; 87(4): 698-711, 2015 Apr.
Article
in English
| MEDLINE | ID: mdl-25607108
10.
Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant.
Blood
; 120(22): 4292-5, 2012 Nov 22.
Article
in English
| MEDLINE | ID: mdl-23047823
11.
Extended high cut-off haemodialysis for myeloma cast nephropathy in Auckland, 2008-2012.
Nephrology (Carlton)
; 19(7): 432-5, 2014 Jul.
Article
in English
| MEDLINE | ID: mdl-24931113
12.
Immunoglobulin free light chain levels and recovery from myeloma kidney on treatment with chemotherapy and high cut-off haemodialysis.
Nephrol Dial Transplant
; 27(10): 3823-8, 2012 Oct.
Article
in English
| MEDLINE | ID: mdl-22273664
13.
Diagnostic accuracy of monoclonal antibody based serum immunoglobulin free light chain immunoassays in myeloma cast nephropathy.
BMC Clin Pathol
; 12: 12, 2012 Aug 09.
Article
in English
| MEDLINE | ID: mdl-22873484
14.
Early reduction of serum-free light chains associates with renal recovery in myeloma kidney.
J Am Soc Nephrol
; 22(6): 1129-36, 2011 Jun.
Article
in English
| MEDLINE | ID: mdl-21511832
15.
Medium Cutoff Versus High-Flux Hemodialysis Membranes and Clinical Outcomes: A Cohort Study Using Inverse Probability Treatment Weighting.
Kidney Med
; 4(4): 100431, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-35492142
16.
The biology of immunoglobulin free light chains and kidney injury.
Kidney Int
; 79(12): 1289-301, 2011 Jun.
Article
in English
| MEDLINE | ID: mdl-21490587
17.
Aggregated serum free light chains may prevent adequate removal by high cut-off haemodialysis.
Nephrol Dial Transplant
; 26(4): 1438, 2011 Apr.
Article
in English
| MEDLINE | ID: mdl-21406545
18.
Expanded Hemodialysis and Its Effects on Hospitalizations and Medication Usage: A Cohort Study.
Nephron
; 145(2): 179-187, 2021.
Article
in English
| MEDLINE | ID: mdl-33596561
19.
Classification of Uremic Toxins and Their Role in Kidney Failure.
Clin J Am Soc Nephrol
; 16(12): 1918-1928, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34233920
20.
Effect of a medium cut-off dialyzer on protein-bound uremic toxins and mineral metabolism markers in patients on hemodialysis.
Hemodial Int
; 2021 Mar 28.
Article
in English
| MEDLINE | ID: mdl-33779046